Member Info for Timster

Medusa also have NHS contract, and one hell of a brochure

Is it us though???

It either Cleeves or it doesn't

Having studied the language of Big Al over many years, shortly=with the next year, early=anyone's guess, which is what this thread is about. As always occurs when Allan gives a vague time line.
I'm going for 14th Feb as he's a big romantic according to sauces

"Atrocious market conditions for biotech companies cited."

Yet Avacta managed to raise, interesting....

Very soon

Happy Christmas waggy!

Got any examples of these companies beating avacta to chemo with very few side affects?

It'll all be down to you, when do we thank you?

One and all!

May the new year bring us the news we've all been waiting for and the revolution in cancer care that will benefit so many lives.

Was that using the avactarians calendar?

And that's why affidx was doomed to fail (in the UK)

But it did mean that the diagnostics division produced a commercial product and the new line of commercial products can follow a similar (stream lined) process

Wouldn't want to be out on new year's eve...

I doubt it as that would really give it away.

We'll see a headline in the morning of the science day.

KOL's are a great addition, don't forget you have to pay them for their opinions too.

Q4 slipped into early Jan....
With the science day booked in we can be pretty sure that's the hard deadline, everything we've been speculating about the trial will be revealed.

Or is it just a new house announcement in chelsea?

That'd be the £50 before Christmas prediction, it was with the TMAC update.

£50 in march instead now.
£200 by next Christmas

From the 21 annual report
Good progress is being made in the in-house Affimer® and TMAC® programmes. These preclinical programmes, along with the commercial collaborations, are the focus of in-house research activities and the Company plans to provide a full technical update to shareholders during 2022 when sufficient pre-clinical data has been gathered so that the development path and associated risks can described in detail.

I'm confused, we are in a death spiral , hence the plea for help in February

It's not obvious if you haven't followed the story for two years.

Keep chomping

3 to 4 weeks till that early Jan update
Maybe 15 ish trading days , so no rush.

But they could launch some new tests or update us in TMAC or affixyell or numerous other things in the meantime